Algorae Pharmaceuticals: Notice of Annual General Meeting/Proxy Form

Oct 7, 2026 at 1:46 AM EDT · Issued by Algorae Pharmaceuticals Limited via ASX

Filed with ASX · Oct 7, 2026 at 1:46 AM EDT · 32 pages · English

On 6ix: 6ix.com/news/notice-of-annual-general-meetingproxy-form-219

Release

Algorae Pharmaceuticals Limited [ABN: 14 104 028 042] Level 23, Rialto South Tower, 525 Collins St, Melbourne VIC 3000 P: +61 422 180 317 2026 Algorae Pharmaceuticals Limited Annual General Meeting Notice and Proxy Form Notice is hereby given that the Annual General Meeting (Meeting) of...

Algorae Pharmaceuticals Limited on 6ix

Earlier from Algorae Pharmaceuticals

Change of Director's Interest Notice - DHSep 30
Date of AGM and Closing Date for Director NominationsSep 9
Notification of cessation of securities - 1AISep 2
Appendix 4E and 2026 Annual ReportAug 31
Appendix 4G and Corporate Governance StatementAug 31

Later from Algorae Pharmaceuticals

Peter Mac partners with Algorae on 3rd AI validation programOct 15
Algorae executes Licence & Supply Agreement with UmedicaOct 18
Updated Securities Trading PolicyOct 28
Quarterly Activities Report and Appendix 4C Cash Flow ReportOct 29
Corporate PresentationOct 29

All Algorae Pharmaceuticals news releases

Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.

Follow Algorae Pharmaceuticals